These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25430994)

  • 1. Structural basis for targeting the ribosomal protein S1 of Mycobacterium tuberculosis by pyrazinamide.
    Yang J; Liu Y; Bi J; Cai Q; Liao X; Li W; Guo C; Zhang Q; Lin T; Zhao Y; Wang H; Liu J; Zhang X; Lin D
    Mol Microbiol; 2015 Mar; 95(5):791-803. PubMed ID: 25430994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis ribosomal protein S1 (RpsA) and variants with truncated C-terminal end show absence of interaction with pyrazinoic acid.
    Vallejos-Sánchez K; Lopez JM; Antiparra R; Toscano E; Saavedra H; Kirwan DE; Amzel LM; Gilman RH; Maruenda H; Sheen P; Zimic M
    Sci Rep; 2020 May; 10(1):8356. PubMed ID: 32433489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.
    Shi W; Zhang X; Jiang X; Yuan H; Lee JS; Barry CE; Wang H; Zhang W; Zhang Y
    Science; 2011 Sep; 333(6049):1630-2. PubMed ID: 21835980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA.
    Dillon NA; Peterson ND; Feaga HA; Keiler KC; Baughn AD
    Sci Rep; 2017 Jul; 7(1):6135. PubMed ID: 28733601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Pyrazinamide Drug Resistance Mechanism of Clinical Mutants T370P and W403G in Ribosomal Protein S1 of Mycobacterium tuberculosis.
    Rehman AU; Khan MT; Liu H; Wadood A; Malik SI; Chen HF
    J Chem Inf Model; 2019 Apr; 59(4):1584-1597. PubMed ID: 30810312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance.
    Khan MT; Khan A; Rehman AU; Wang Y; Akhtar K; Malik SI; Wei DQ
    Sci Rep; 2019 May; 9(1):7482. PubMed ID: 31097767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
    Akhmetova A; Kozhamkulov U; Bismilda V; Chingissova L; Abildaev T; Dymova M; Filipenko M; Ramanculov E
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing RpsA Point Mutations Δ438A and D123A into the Chromosome of Mycobacterium tuberculosis Confirms Their Role in Causing Resistance to Pyrazinamide.
    Shi W; Cui P; Niu H; Zhang S; Tønjum T; Zhu B; Zhang Y
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30858213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
    Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1.
    Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T
    ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    Zhang Y; Scorpio A; Nikaido H; Sun Z
    J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Chain Fatty Acyl Coenzyme A Ligase FadD2 Mediates Intrinsic Pyrazinamide Resistance in Mycobacterium tuberculosis.
    Rosen BC; Dillon NA; Peterson ND; Minato Y; Baughn AD
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical shift assignments of Ribosomal protein S1 from Mycobacterium tuberculosis.
    Fu J; Huang B; Lin D; Liao X
    Biomol NMR Assign; 2017 Oct; 11(2):133-136. PubMed ID: 28258550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging insight of whole genome sequencing coupled with protein structure prediction into the pyrazinamide-resistance signature of Mycobacterium tuberculosis.
    Huang CK; Yu MC; Hung CS; Lin JC
    Int J Antimicrob Agents; 2024 Apr; 63(4):107053. PubMed ID: 38081550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations.
    Gu Y; Yu X; Jiang G; Wang X; Ma Y; Li Y; Huang H
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):207-11. PubMed ID: 26775806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
    Shi W; Chen J; Feng J; Cui P; Zhang S; Weng X; Zhang W; Zhang Y
    Emerg Microbes Infect; 2014 Aug; 3(8):e58. PubMed ID: 26038753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
    Zimic M; Loli S; Gilman RH; Gutierrez A; Fuentes P; Cotrina M; Kirwan D; Sheen P
    Microb Drug Resist; 2012 Aug; 18(4):372-5. PubMed ID: 22372927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
    Zhang Y; Permar S; Sun Z
    J Med Microbiol; 2002 Jan; 51(1):42-49. PubMed ID: 11800471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis.
    Modlin SJ; Marbach T; Werngren J; Mansjö M; Hoffner SE; Valafar F
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.